Los Angeles, CA21 Active Studies

Acute Myeloid Leukemia Clinical Trials in Los Angeles, CA

Find 21 actively recruiting acute myeloid leukemia clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

21
Active Trials
15
Sponsors
9,161
Enrolling

Recruiting Acute Myeloid Leukemia Studies in Los Angeles

About Acute Myeloid Leukemia Clinical Trials in Los Angeles

Acute myeloid leukemia (AML) is a fast-growing cancer of the blood and bone marrow characterized by abnormal myeloid cells. It is the most common acute leukemia in adults. Treatment typically includes intensive chemotherapy and may involve stem cell transplant.

There are currently 21 acute myeloid leukemia clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 9,161 participants. Research is being sponsored by Beat AML, LLC, Kura Oncology, Inc., Stichting Hemato-Oncologie voor Volwassenen Nederland and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Acute Myeloid Leukemia Clinical Trials in Los Angeles — FAQ

Are there acute myeloid leukemia clinical trials in Los Angeles?

Yes, there are 21 acute myeloid leukemia clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What acute myeloid leukemia treatments are being tested?

The 21 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for acute myeloid leukemia.

Data updated October 18, 2026 from ClinicalTrials.gov